Clinically elevated cardiac biomarkers, i.e., serum troponin and BNP, abnormal EKG, and new left ventricular dysfunction, can raise the suspicion of COVID-19 myocarditis; however, an endomyocardial biopsy is the only diagnostic modality for COVID-19 myocarditis. Here, NPPB is linked to COVID-19.